{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:18:22Z","timestamp":1790421502199,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01MH085666"],"award-info":[{"award-number":["R01MH085666"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21MH110678"],"award-info":[{"award-number":["R21MH110678"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NARSAD Independent Award 2015"},{"name":"Pennsylvania Commonwealth","award":["4100072545"],"award-info":[{"award-number":["4100072545"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.neuropharm.2018.05.019","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T11:43:43Z","timestamp":1526298223000},"page":"359-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Juvenile treatment with mGluR2\/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3\u03b2"],"prefix":"10.1016","volume":"137","author":[{"given":"Bo","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8585-3082","authenticated-orcid":false,"given":"Wen-Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.05.019_bib1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/schbul\/sbp113","article-title":"Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis","volume":"37","author":"Allen","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tics.2015.09.009","article-title":"How schizophrenia develops: cognitive and brain mechanisms underlying onset of psychosis","volume":"19","author":"Cannon","year":"2015","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biopsych.2014.05.023","article-title":"Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk","volume":"77","author":"Cannon","year":"2015","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0306-4522(94)90428-6","article-title":"Metabotropic glutamate receptors are differentially regulated during development","volume":"61","author":"Catania","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1124\/mol.107.034942","article-title":"Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons","volume":"72","author":"Chen","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000371887","article-title":"Prodromal symptom severity predicts accelerated gray matter reduction and third ventricle expansion among clinically high risk youth developing psychotic disorders","volume":"1","author":"Chung","year":"2015","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(96)00163-5","article-title":"Response learning of rats in a Morris water maze: involvement of the medical prefrontal cortex","volume":"85","author":"de Bruin","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nprot.2006.2","article-title":"T-maze alternation in the rodent","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000066741","article-title":"Differential localization of metabotropic glutamate receptors during postnatal development","volume":"24","author":"Defagot","year":"2002","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib10","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1523\/JNEUROSCI.4565-14.2015","article-title":"The mediodorsal thalamus drives feedforward inhibition in the anterior cingulate cortex via parvalbumin interneurons","volume":"35","author":"Delevich","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12888-014-0351-3","article-title":"A\u00a0double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia","volume":"14","author":"Downing","year":"2014","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib12","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/npp.2013.101","article-title":"Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia","volume":"38","author":"Du","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00441-006-0266-5","article-title":"Metabotropic glutamate receptors","volume":"326","author":"Ferraguti","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/npp.2011.76","article-title":"A\u00a0novel alpha5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia","volume":"36","author":"Gill","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.biopsych.2006.05.046","article-title":"Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development","volume":"60","author":"Goto","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jnc.14101","article-title":"Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia","volume":"143","author":"Gulchina","year":"2017","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2167702614533949","article-title":"Contributions of feature binding during encoding and functional connectivity of the medial temporal lobe structures to episodic memory deficits across the prodromal and first-episode phases of schizophrenia","volume":"3","author":"Haut","year":"2015","journal-title":"Clin Psychol Sci"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.197604","article-title":"Selective destruction of neurons by a transmitter agonist","volume":"198","author":"Herndon","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pbb.2006.05.021","article-title":"Effects of the mGluR2\/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat","volume":"84","author":"Imre","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/cercor\/bhx005","article-title":"mGluR2 versus mGluR3 metabotropic glutamate receptors in primate dorsolateral prefrontal cortex: postsynaptic mGluR3 strengthen working memory networks","volume":"28","author":"Jin","year":"2018","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib21","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/mp.2016.129","article-title":"mGluR2\/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions","volume":"22","author":"Jin","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1176\/appi.ajp.162.6.1200","article-title":"Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia","volume":"162","author":"Kolluri","year":"2005","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuroscience.2006.08.004","article-title":"Peri-pubertal maturation after developmental disturbance: a model for psychosis onset in the rat","volume":"143","author":"Le Pen","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0269881110387839","article-title":"Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol","volume":"25","author":"Le Pen","year":"2011","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.biopsych.2005.09.005","article-title":"Generalized and specific neurocognitive deficits in prodromal schizophrenia","volume":"59","author":"Lencz","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nlm.2017.02.004","article-title":"Juvenile treatment with a novel mGluR2 agonist\/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia","volume":"140","author":"Li","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pnpbp.2015.02.012","article-title":"Perspectives on the mGluR2\/3 agonists as a therapeutic target for schizophrenia: still promising or a dead end?","volume":"60","author":"Li","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2015.08.019","article-title":"LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment","volume":"273","author":"Li","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib29","doi-asserted-by":"crossref","first-page":"15551","DOI":"10.1523\/JNEUROSCI.3336-09.2009","article-title":"Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex","volume":"29","author":"Li","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0165-3806(96)00141-1","article-title":"Age-dependent effects of glutamate toxicity in the hippocampus","volume":"97","author":"Liu","year":"1996","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib31","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1523\/JNEUROSCI.5419-08.2009","article-title":"A\u00a0loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia","volume":"29","author":"Lodge","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib32","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","article-title":"Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia","volume":"27","author":"Lodge","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/nm.4225","article-title":"Developmental timing and critical windows for the treatment of psychiatric disorders","volume":"22","author":"Marin","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib34","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.neuroscience.2007.02.053","article-title":"Group II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex","volume":"146","author":"Mateo","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0361-9230(95)02009-G","article-title":"Prefrontal cortical mediation of rats' place learning in a modified water maze","volume":"38","author":"Mogensen","year":"1995","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neubiorev.2015.06.022","article-title":"NR2B subunit in the prefrontal cortex: a double-edged sword for working memory function and psychiatric disorders","volume":"56","author":"Monaco","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsych.2006.01.003","article-title":"A\u00a0neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia","volume":"60","author":"Moore","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fphar.2016.00130","article-title":"Group II metabotropic glutamate receptors as targets for novel antipsychotic drugs","volume":"7","author":"Muguruza","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/cercor\/bhs370","article-title":"Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model","volume":"24","author":"Murray","year":"2014","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.schres.2004.03.002","article-title":"A\u00a0developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder","volume":"71","author":"Murray","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0306-4522(95)00533-1","article-title":"The metabotropic glutamate receptors, MGLUR2 and MGLUR3, show unique postsynaptic, presynaptic and glial localizations","volume":"71","author":"Petralia","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib43","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.neuropharm.2011.04.006","article-title":"Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia","volume":"62","author":"Phillips","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/schbul\/sbr168","article-title":"CNTRICS imaging biomarkers final task selection: long-term memory and reinforcement learning","volume":"38","author":"Ragland","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/schbul\/sbn134","article-title":"CNTRICS final task selection: long-term memory","volume":"35","author":"Ragland","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.bjp.0703610","article-title":"Developmental regulation of hippocampal excitatory synaptic transmission by metabotropic glutamate receptors","volume":"131","author":"Ross","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/FBP.0b013e3283242f57","article-title":"Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition","volume":"20","author":"Schlumberger","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib48","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1038\/tp.2015.115","article-title":"Schizophrenia: a tale of two critical periods for prefrontal cortical development","volume":"5","author":"Selemon","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib49","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/npp.2012.180","article-title":"Gestational methylazoxymethanol exposure leads to NMDAR dysfunction in hippocampus during early development and lasting deficits in learning","volume":"38","author":"Snyder","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fncel.2013.00031","article-title":"NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia","volume":"7","author":"Snyder","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(01)00305-0","article-title":"Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites","volume":"106","author":"Tamaru","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib53","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuron.2016.01.025","article-title":"Developmental inhibition of Gsk3 rescues behavioral and neurophysiological deficits in a mouse model of schizophrenia predisposition","volume":"89","author":"Tamura","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1113\/jphysiol.2003.056812","article-title":"Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurons of rat prefrontal cortex","volume":"554","author":"Tyszkiewicz","year":"2004","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib55","doi-asserted-by":"crossref","first-page":"16791","DOI":"10.1073\/pnas.0804318105","article-title":"A\u00a0specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib56","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/npp.2009.20","article-title":"Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex","volume":"34","author":"Wang","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib57","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1113\/jphysiol.2010.187591","article-title":"Development of calcium-permeable AMPA receptors and their correlation with NMDA receptors in fast-spiking interneurons of rat prefrontal cortex","volume":"588","author":"Wang","year":"2010","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib58","article-title":"Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib59","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1523\/JNEUROSCI.19-21-09587.1999","article-title":"Synaptic basis of cortical persistent activity: the importance of NMDA receptors to working memory","volume":"19","author":"Wang","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnmol.2012.00080","article-title":"Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase","volume":"5","author":"Wildburger","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib61","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1073\/pnas.1217832110","article-title":"Homologous involvement of striatum and prefrontal cortex in rodent and human water maze learning","volume":"110","author":"Woolley","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.05.019_bib62","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/npp.2011.12","article-title":"Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt\/GSK-3beta pathway in adult rat prefrontal cortex","volume":"36","author":"Xi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.05.019_bib63","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1038\/npp.2016.110","article-title":"GSK3beta hyperactivity during an early critical period impairs prefrontal synaptic plasticity and induces lasting deficits in spine morphology and working memory","volume":"41","author":"Xing","year":"2016","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818302429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818302429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T19:39:54Z","timestamp":1569181194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818302429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":63,"alternative-id":["S0028390818302429"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.05.019","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile treatment with mGluR2\/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3\u03b2","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}